Tocagen Inc (NASDAQ:TOCA) gapped down before the market opened on Thursday . The stock had previously closed at $3.86, but opened at $5.41. Tocagen shares last traded at $4.65, with a volume of 16371 shares traded.
Several brokerages have recently weighed in on TOCA. Zacks Investment Research downgraded Tocagen from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. HC Wainwright reaffirmed a “buy” rating and issued a $14.50 target price on shares of Tocagen in a research note on Thursday, May 9th. ValuEngine raised Tocagen from a “hold” rating to a “buy” rating in a research note on Monday, April 29th. Leerink Swann initiated coverage on Tocagen in a research note on Monday, April 15th. They issued a “market perform” rating and a $10.26 target price for the company. Finally, Svb Leerink initiated coverage on Tocagen in a research note on Monday, April 15th. They issued a “market perform” rating and a $11.00 target price for the company. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $16.75.
The company has a market capitalization of $209.76 million, a PE ratio of -1.84 and a beta of 3.29. The company has a quick ratio of 5.05, a current ratio of 5.05 and a debt-to-equity ratio of 0.75.
Tocagen (NASDAQ:TOCA) last issued its earnings results on Tuesday, May 7th. The company reported ($0.74) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.75) by $0.01. Tocagen had a negative return on equity of 108.08% and a negative net margin of 294.74%. The business had revenue of $0.01 million during the quarter, compared to the consensus estimate of $2.01 million. Research analysts predict that Tocagen Inc will post -2.93 EPS for the current year.
Institutional investors and hedge funds have recently modified their holdings of the business. BNP Paribas Arbitrage SA increased its stake in shares of Tocagen by 72,350.0% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,347 shares of the company’s stock worth $47,000 after acquiring an additional 4,341 shares during the last quarter. Meeder Asset Management Inc. grew its holdings in shares of Tocagen by 162.8% during the 4th quarter. Meeder Asset Management Inc. now owns 9,961 shares of the company’s stock worth $82,000 after purchasing an additional 6,170 shares during the period. Stratos Wealth Partners LTD. grew its holdings in shares of Tocagen by 9.0% during the 4th quarter. Stratos Wealth Partners LTD. now owns 11,449 shares of the company’s stock worth $94,000 after purchasing an additional 949 shares during the period. Caption Management LLC purchased a new position in shares of Tocagen during the 4th quarter worth $98,000. Finally, Creative Planning purchased a new position in shares of Tocagen during the 1st quarter worth $117,000. 33.16% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Zolmax and is owned by of Zolmax. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://zolmax.com/investing/tocagen-toca-shares-gap-down-to-5-41/3093254.html.
Tocagen Company Profile (NASDAQ:TOCA)
Tocagen Inc, a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells.
Featured Story: Limitations of the P/E Growth ratio
Receive News & Ratings for Tocagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tocagen and related companies with MarketBeat.com's FREE daily email newsletter.